Chief Executive Officer
CurrentProminex was founded in 2018 by experienced diagnostics industry executives with a goal to develop Molecular Point-of-Care Testing (MDx POCT) solutions for infectious diseases. The patent-protected amplification chemistry and detection technologies utilized in our Prominex System enables the delivery of accurate sample-to-answer test results in less than 5.